Bioceres Crop Solutions C... (BIOX)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Bioceres Crop Solutions Corp. Statistics
Share Statistics
Bioceres Crop Solutions Corp. has 62.71M shares outstanding. The number of shares has increased by 0.04% in one year.
Shares Outstanding | 62.71M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | 0.04% |
Owned by Institutions (%) | n/a |
Shares Floating | 33.43M |
Failed to Deliver (FTD) Shares | 1.23K |
FTD / Avg. Volume | 0.59% |
Short Selling Information
The latest short interest is 648.43K, so 1.03% of the outstanding shares have been sold short.
Short Interest | 648.43K |
Short % of Shares Out | 1.03% |
Short % of Float | 2% |
Short Ratio (days to cover) | 2.76 |
Valuation Ratios
The PE ratio is 215.64 and the forward PE ratio is 10.4. Bioceres Crop Solutions Corp.'s PEG ratio is 0.19.
PE Ratio | 215.64 |
Forward PE | 10.4 |
PS Ratio | 1.5 |
Forward PS | 0.9 |
PB Ratio | 2.23 |
P/FCF Ratio | 36.94 |
PEG Ratio | 0.19 |
Enterprise Valuation
Bioceres Crop Solutions Corp. has an Enterprise Value (EV) of 1.04B.
EV / Earnings | 320.52 |
EV / Sales | 2.24 |
EV / EBITDA | 18.75 |
EV / EBIT | 23.19 |
EV / FCF | 54.9 |
Financial Position
The company has a current ratio of 1.24, with a Debt / Equity ratio of 0.86.
Current Ratio | 1.24 |
Quick Ratio | 0.86 |
Debt / Equity | 0.86 |
Total Debt / Capitalization | 46.32 |
Cash Flow / Debt | 0.15 |
Interest Coverage | 1.67 |
Financial Efficiency
Return on equity (ROE) is 0.01% and return on capital (ROIC) is 4.51%.
Return on Equity (ROE) | 0.01% |
Return on Assets (ROA) | 0% |
Return on Capital (ROIC) | 4.51% |
Revenue Per Employee | 1.16M |
Profits Per Employee | 8.11K |
Employee Count | 400 |
Asset Turnover | 0.55 |
Inventory Turnover | 2.24 |
Taxes
Income Tax | 3.78M |
Effective Tax Rate | 0.38 |
Stock Price Statistics
The stock price has increased by -48.82% in the last 52 weeks. The beta is 0.47, so Bioceres Crop Solutions Corp.'s price volatility has been higher than the market average.
Beta | 0.47 |
52-Week Price Change | -48.82% |
50-Day Moving Average | 6.63 |
200-Day Moving Average | 9.2 |
Relative Strength Index (RSI) | 54.71 |
Average Volume (20 Days) | 206.75K |
Income Statement
In the last 12 months, Bioceres Crop Solutions Corp. had revenue of 464.83M and earned 3.24M in profits. Earnings per share was 0.05.
Revenue | 464.83M |
Gross Profit | 181.59M |
Operating Income | 44.82M |
Net Income | 3.24M |
EBITDA | 55.46M |
EBIT | 44.82M |
Earnings Per Share (EPS) | 0.05 |
Balance Sheet
The company has 44.47M in cash and 270.95M in debt, giving a net cash position of -226.47M.
Cash & Cash Equivalents | 44.47M |
Total Debt | 270.95M |
Net Cash | -226.47M |
Retained Earnings | -10.66M |
Total Assets | 827.50M |
Working Capital | 80.50M |
Cash Flow
In the last 12 months, operating cash flow was 41.72M and capital expenditures -22.78M, giving a free cash flow of 18.93M.
Operating Cash Flow | 41.72M |
Capital Expenditures | -22.78M |
Free Cash Flow | 18.93M |
FCF Per Share | 0.3 |
Margins
Gross margin is 39.07%, with operating and profit margins of 9.64% and 0.7%.
Gross Margin | 39.07% |
Operating Margin | 9.64% |
Pretax Margin | 2.16% |
Profit Margin | 0.7% |
EBITDA Margin | 11.93% |
EBIT Margin | 9.64% |
FCF Margin | 4.07% |
Dividends & Yields
BIOX does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | 0.72% |
FCF Yield | 4.34% |
Analyst Forecast
The average price target for BIOX is $13, which is 86.8% higher than the current price. The consensus rating is "Buy".
Price Target | $13 |
Price Target Difference | 86.8% |
Analyst Consensus | Buy |
Analyst Count | 4 |
Scores
Altman Z-Score | 1.36 |
Piotroski F-Score | 7 |